These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23613251)

  • 1. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.
    Sun YW; Xuan Q; Shu QA; Wu SS; Chen H; Xiao J; Xiang P; Zhu YP; Wang FL; Zhao ST
    Genet Mol Res; 2013 Apr; 12(2):1045-53. PubMed ID: 23613251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor-C associated with computed tomography used in the diagnosis of lymph node metastasis of bladder carcinoma.
    Li Z; Qi F; Miao J; Zu X; He W; Wang L; Qi L
    Arch Med Res; 2010 Nov; 41(8):606-10. PubMed ID: 21199729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor in primary superficial bladder cancer.
    Chow NH; Liu HS; Chan SH; Cheng HL; Tzai TS
    Anticancer Res; 1999; 19(5C):4593-7. PubMed ID: 10650816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
    Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up.
    Bartoletti R; Cai T; Nesi G; Sardi I; Rizzo M
    Oncol Rep; 2005 Jul; 14(1):251-5. PubMed ID: 15944797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor, receptor KDR and p53 protein in transitional cell carcinoma of the bladder.
    Liu L; Zhu D; Gao R; Guo H
    Urol Int; 2008; 81(1):72-6. PubMed ID: 18645275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma.
    Choi YD; Cho NH; Ahn HS; Cho KS; Cho SY; Yang WJ
    J Urol; 2007 Mar; 177(3):1174-8. PubMed ID: 17296440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma].
    Guo ZH; Mei H; Huang J; Li SY
    Ai Zheng; 2003 Mar; 22(3):307-9. PubMed ID: 12654193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.
    Crew JP; O'Brien T; Bradburn M; Fuggle S; Bicknell R; Cranston D; Harris AL
    Cancer Res; 1997 Dec; 57(23):5281-5. PubMed ID: 9393750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression.
    Yang CC; Chu KC; Yeh WM
    Urol Oncol; 2004; 22(1):1-6. PubMed ID: 14969795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER.
    Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A
    East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
    Suzuki K; Morita T; Tokue A
    Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
    He XF; Wen DG; Hou JQ; He J; Cen JN
    Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical study.
    Makboul R; Refaiy AE; Badary FA; Abdelkawi IF; Merseburger AS; Mohammed RA
    Korean J Urol; 2015 Jan; 56(1):31-40. PubMed ID: 25598934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of survivin and livin predicts early recurrence in non-muscle invasive bladder cancer.
    Xi RC; Sheng YR; Chen WH; Sheng L; Gang JJ; Tong Z; Shan Z; Ying GH; Dong LC
    J Surg Oncol; 2013 Apr; 107(5):550-4. PubMed ID: 23090902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.
    Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates.
    Crew JP; O'Brien T; Bicknell R; Fuggle S; Cranston D; Harris AL
    J Urol; 1999 Mar; 161(3):799-804. PubMed ID: 10022687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.